# Memantine and Naltrexone Treatment for Opioid Dependence

> **NCT00125515** · PHASE2 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 81 (actual)

## Conditions studied

- Opioid Dependence

## Interventions

- **DRUG:** Memantine
- **DRUG:** Naltrexone

## Key facts

- **NCT ID:** NCT00125515
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2018-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00125515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00125515, "Memantine and Naltrexone Treatment for Opioid Dependence". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00125515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*